Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure

Funct Integr Genomics. 2022 Feb;22(1):89-112. doi: 10.1007/s10142-021-00813-9. Epub 2021 Dec 6.

Abstract

Epigenetic modifications viz. DNA methylation, histone modifications, and RNA-based alterations play a crucial role in the development of cardiovascular diseases. In this study, we investigated DNA methylation with an aim to reveal the epigenetic etiology of heart failure. Sprague-Dawley rats surviving myocardial infarction developed acute heart failure in 1 week. Genomic DNA methylation changes were profiled by bisulfite sequencing, and gene expression levels were analyzed by RNA-seq in failing and sham-operation hearts. A total of 3480 differentially methylated genes in the promoter regions including transcriptional start site and 1934 transcriptome-altered genes were identified in the defected hearts. Common differential genes were enriched by the gene ontology, Kyoto Encyclopedia of Genes and Genomes pathway, and protein-protein interaction for HF phenotypes. Among these, Mettl11b, HDAC3, HDAC11, ubiquitination-related genes, and snoRNAs are new epigenetic classifiers that had not been reported yet, which may be important regulators in HF.

Keywords: DNA methylation; Epigenetic; Heart failure; Promoter; Transcriptome.

MeSH terms

  • Animals
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Heart Failure* / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Transcriptome*